Furthermore, in a recent clinical study conducted using ex vivo lung tissue from patients with COPD, the EGFR inhibitor BIBW 2948 showed some efficacy in inhibiting EGFR phosphorylation and a tendency toward reducing mucous cell metaplasia. This evidence concerns the gene EGFR and chronic obstructive pulmonary disease.